About BioAtla, Inc.
BioAtla is a protein therapeutic company that uses discovery and evolution to develop safer and more potent drugs for the treatment of cancer. The culmination of our discovery and evolution expertise and more than 150 issued patents and patent applications is our Conditionally Active Biologics (CAB) platform, whereby monoclonal antibodies or other biologics can be engineered for selective conditional activation, for example preferential binding under the unique conditions of the tumor microenvironment. This improvement in tumor selectivity helps address the issue of on-target toxicity and improve therapeutic index. BioAtla is applying these technologies in our own pipeline and in partnerships to ultimately deliver better immunotherapies for cancer.
|
|
|
11-50 employees
View all BioAtla, Inc. employees
|
|
Biotechnology
|
|
11085 Torreyana Rd, San Diego, California 92121, US
|
|
2007
|
|
Antibody Evolution And Engineering, Conditionally Active Biologics, Development Of Novel Cancer Immunotherapies, Protein Evolution And Engineering
|
BioAtla, Inc. Alternatives
BioAtla, Inc. Staff Directory
Search BioAtla, Inc. Staff Directory
Find accurate personal emails, work emails and phone numbers for employees
Supercharge your
Prospecting &
Outreach with
ContactOut
Supercharge your Prospecting &
Outreach with ContactOut
Find countless prospects outside of LinkedIn fast
Accelerate prospecting with instant access to 350M professionals from 40M companies with the right contact details.
